Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 306

    1.

    Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.

    McGill JB, Cole TG, Nowatzke W, Houghton S, Ammirati EB, Gautille T, Sarno MJ; U.S. trial of the GlycoMark assay.

    Diabetes Care. 2004 Aug;27(8):1859-65.PMID: 15277408 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

    Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

    Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.PMID: 17919531 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

    Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

    Diabetes Care. 2003 Jun;26(6):1759-63.PMID: 12766106 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.

    Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E.

    Diabetes Care. 2002 Oct;25(10):1840-4.PMID: 12351488 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.

    Yamanouchi T, Kawasaki T, Yoshimura T, Inoue T, Koshibu E, Ogata N, Funato H, Akaoka I, Miyashita H.

    Diabetes Care. 1998 Apr;21(4):619-24.PMID: 9571353 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?

    Narbonne H, Renacco E, Pradel V, Portugal H, Vialettes B.

    Diabetes Metab. 2001 Nov;27(5 Pt 1):598-603.PMID: 11694860 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.

    Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R.

    Diabetes Metab. 2008 Dec;34(6 Pt 1):568-73. Epub 2008 Oct 14.PMID: 18922724 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.

    Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L, Miyashita H.

    Lancet. 1996 Jun 1;347(9014):1514-8.PMID: 8684103 [PubMed - indexed for MEDLINE]Related articles

    11.

    1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.

    Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S.

    Diabetes Care. 2006 Jun;29(6):1214-9.PMID: 16731998 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    17.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

    Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y; Osaka CKD Expert Research Group.

    J Am Soc Nephrol. 2007 Mar;18(3):896-903. Epub 2007 Jan 31.PMID: 17267743 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data